Sulforaphane downregulates mitochondrial TIGAR via inhibiting mitochondrial transmembrane assembly and LONP1/CASP3

Dongxue Wu1, Sitian Zhang2, Yaheng Wu3

  • 1Neonatal Intensive Care Unit, Beijing Obstetrics and Gynecology Hospital, Capital Medical University, Beijing Maternal and Child Health Care Hospital, Beijing, China.

Insights

Sulforaphane (SFN) targets TP53-induced glycolysis and apoptosis regulator (TIGAR) in non-small cell lung cancer (NSCLC). SFN disrupts TIGAR

Area of Science:

  • Oncology
  • Molecular Biology
  • Biochemistry

Background:

  • TP53-induced glycolysis and apoptosis regulator (TIGAR) is upregulated in non-small cell lung cancer (NSCLC).
  • High TIGAR expression correlates with poor prognosis and higher pathological grading in NSCLC patients.
  • The precise mechanism by which sulforaphane (SFN) affects TIGAR in NSCLC remains unclear.

Purpose of the Study:

  • To elucidate the mechanism of SFN's action on TIGAR in NSCLC.
  • To investigate SFN's impact on TIGAR localization and function within NSCLC cells.
  • To explore the potential of targeting TIGAR for anti-NSCLC therapy.

Main Methods:

  • Western blot analysis of cytosolic and mitochondrial fractions.
  • Immunoprecipitation to assess protein interactions.
  • Analysis of reactive oxygen species (ROS) and apoptosis markers.

Main Results:

  • SFN downregulates TIGAR, α-tubulin, Timm23, and Timm17A.
  • SFN disrupts microtubule-mediated mitochondrial import of TIGAR by reducing α-tubulin interactions.
  • SFN downregulates LONP1, leading to TIGAR cleavage, decreased NADPH, elevated ROS, and apoptosis.

Conclusions:

  • SFN inhibits NSCLC progression by targeting TIGAR.
  • Disruption of TIGAR's mitochondrial import and subsequent cleavage are key mechanisms.
  • Targeting TIGAR and its related pathways presents a promising therapeutic strategy for NSCLC.

Related Concept Videos

The Extrinsic Apoptotic Pathway01:17

The Extrinsic Apoptotic Pathway

The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors are of three kinds RI, RII, and RIII. The RI...
Cellular Injury V: Apoptosis and Autophagy01:22

Cellular Injury V: Apoptosis and Autophagy

Cells respond to damage and stress through highly coordinated processes that decide whether they survive or undergo controlled self-destruction. Two major pathways involved in this regulation are apoptosis, a type of programmed cell death, and autophagy, a survival mechanism that helps cells adapt to adverse conditions.ApoptosisApoptosis removes aged or injured cells to maintain tissue balance. During this process, the cell shrinks, chromatin condenses and fragments, and membrane-bound...